Table of Contents 1 Anticoagulants Market Overview 1.1 Product Overview and Scope of Anticoagulants 1.2 Anticoagulants Segment by Type 1.2.1 Global Anticoagulants Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Platelet aggregation inhibitors (PAI) 1.2.3 Low-molecular-weight Heparin (LMWH) 1.2.4 Direct thrombin inhibitor (DTI) 1.2.5 Direct factor Xa inhibitors (DFXa) 1.2.6 Vitamin K antagonists (VKA) 1.2.7 Others 1.3 Anticoagulants Segment by Application 1.3.1 Anticoagulants Sales Comparison by Application: 2020 VS 2026 1.3.2 VTE 1.3.3 ACS/MI 1.3.4 AF 1.3.5 Other 1.4 Global Anticoagulants Market Size Estimates and Forecasts 1.4.1 Global Anticoagulants Revenue 2015-2026 1.4.2 Global Anticoagulants Sales 2015-2026 1.4.3 Anticoagulants Market Size by Region: 2020 Versus 2026 2 Global Anticoagulants Market Competition by Manufacturers 2.1 Global Anticoagulants Sales Market Share by Manufacturers (2015-2020) 2.2 Global Anticoagulants Revenue Share by Manufacturers (2015-2020) 2.3 Global Anticoagulants Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Anticoagulants Manufacturing Sites, Area Served, Product Type 2.5 Anticoagulants Market Competitive Situation and Trends 2.5.1 Anticoagulants Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Anticoagulants Players (Opinion Leaders) 3 Anticoagulants Retrospective Market Scenario by Region 3.1 Global Anticoagulants Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Anticoagulants Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Anticoagulants Market Facts & Figures by Country 3.3.1 North America Anticoagulants Sales by Country 3.3.2 North America Anticoagulants Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Anticoagulants Market Facts & Figures by Country 3.4.1 Europe Anticoagulants Sales by Country 3.4.2 Europe Anticoagulants Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Anticoagulants Market Facts & Figures by Region 3.5.1 Asia Pacific Anticoagulants Sales by Region 3.5.2 Asia Pacific Anticoagulants Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Anticoagulants Market Facts & Figures by Country 3.6.1 Latin America Anticoagulants Sales by Country 3.6.2 Latin America Anticoagulants Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Anticoagulants Market Facts & Figures by Country 3.7.1 Middle East and Africa Anticoagulants Sales by Country 3.7.2 Middle East and Africa Anticoagulants Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Anticoagulants Historic Market Analysis by Type 4.1 Global Anticoagulants Sales Market Share by Type (2015-2020) 4.2 Global Anticoagulants Revenue Market Share by Type (2015-2020) 4.3 Global Anticoagulants Price Market Share by Type (2015-2020) 4.4 Global Anticoagulants Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Anticoagulants Historic Market Analysis by Application 5.1 Global Anticoagulants Sales Market Share by Application (2015-2020) 5.2 Global Anticoagulants Revenue Market Share by Application (2015-2020) 5.3 Global Anticoagulants Price by Application (2015-2020) 6 Company Profiles and Key Figures in Anticoagulants Business 6.1 Sanofi 6.1.1 Corporation Information 6.1.2 Sanofi Description, Business Overview and Total Revenue 6.1.3 Sanofi Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Sanofi Products Offered 6.1.5 Sanofi Recent Development 6.2 Bayer 6.2.1 Bayer Anticoagulants Production Sites and Area Served 6.2.2 Bayer Description, Business Overview and Total Revenue 6.2.3 Bayer Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Bayer Products Offered 6.2.5 Bayer Recent Development 6.3 Boehringer Ingelheim 6.3.1 Boehringer Ingelheim Anticoagulants Production Sites and Area Served 6.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue 6.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Boehringer Ingelheim Products Offered 6.3.5 Boehringer Ingelheim Recent Development 6.4 Johnson & Johnson 6.4.1 Johnson & Johnson Anticoagulants Production Sites and Area Served 6.4.2 Johnson & Johnson Description, Business Overview and Total Revenue 6.4.3 Johnson & Johnson Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Johnson & Johnson Products Offered 6.4.5 Johnson & Johnson Recent Development 6.5 Genentech (Roche) 6.5.1 Genentech (Roche) Anticoagulants Production Sites and Area Served 6.5.2 Genentech (Roche) Description, Business Overview and Total Revenue 6.5.3 Genentech (Roche) Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Genentech (Roche) Products Offered 6.5.5 Genentech (Roche) Recent Development 6.6 AstraZeneca 6.6.1 AstraZeneca Anticoagulants Production Sites and Area Served 6.6.2 AstraZeneca Description, Business Overview and Total Revenue 6.6.3 AstraZeneca Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.6.4 AstraZeneca Products Offered 6.6.5 AstraZeneca Recent Development 6.7 Bristol-Myers Squibb 6.6.1 Bristol-Myers Squibb Anticoagulants Production Sites and Area Served 6.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue 6.6.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Bristol-Myers Squibb Products Offered 6.7.5 Bristol-Myers Squibb Recent Development 6.8 Aspen 6.8.1 Aspen Anticoagulants Production Sites and Area Served 6.8.2 Aspen Description, Business Overview and Total Revenue 6.8.3 Aspen Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Aspen Products Offered 6.8.5 Aspen Recent Development 6.9 Lilly 6.9.1 Lilly Anticoagulants Production Sites and Area Served 6.9.2 Lilly Description, Business Overview and Total Revenue 6.9.3 Lilly Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Lilly Products Offered 6.9.5 Lilly Recent Development 6.10 Otsuka 6.10.1 Otsuka Anticoagulants Production Sites and Area Served 6.10.2 Otsuka Description, Business Overview and Total Revenue 6.10.3 Otsuka Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Otsuka Products Offered 6.10.5 Otsuka Recent Development 6.11 Pfizer 6.11.1 Pfizer Anticoagulants Production Sites and Area Served 6.11.2 Pfizer Anticoagulants Description, Business Overview and Total Revenue 6.11.3 Pfizer Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Pfizer Products Offered 6.11.5 Pfizer Recent Development 6.12 Daiichi Sankyo 6.12.1 Daiichi Sankyo Anticoagulants Production Sites and Area Served 6.12.2 Daiichi Sankyo Anticoagulants Description, Business Overview and Total Revenue 6.12.3 Daiichi Sankyo Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Daiichi Sankyo Products Offered 6.12.5 Daiichi Sankyo Recent Development 6.13 The Medicines Company 6.13.1 The Medicines Company Anticoagulants Production Sites and Area Served 6.13.2 The Medicines Company Anticoagulants Description, Business Overview and Total Revenue 6.13.3 The Medicines Company Anticoagulants Sales, Revenue and Gross Margin (2015-2020) 6.13.4 The Medicines Company Products Offered 6.13.5 The Medicines Company Recent Development 7 Anticoagulants Manufacturing Cost Analysis 7.1 Anticoagulants Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Anticoagulants 7.4 Anticoagulants Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Anticoagulants Distributors List 8.3 Anticoagulants Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Anticoagulants Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Anticoagulants by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Anticoagulants by Type (2021-2026) 10.2 Anticoagulants Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Anticoagulants by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Anticoagulants by Application (2021-2026) 10.3 Anticoagulants Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Anticoagulants by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Anticoagulants by Region (2021-2026) 10.4 North America Anticoagulants Estimates and Projections (2021-2026) 10.5 Europe Anticoagulants Estimates and Projections (2021-2026) 10.6 Asia Pacific Anticoagulants Estimates and Projections (2021-2026) 10.7 Latin America Anticoagulants Estimates and Projections (2021-2026) 10.8 Middle East and Africa Anticoagulants Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Anticoagulants Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Anticoagulants Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Anticoagulants Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Anticoagulants Manufacturers Covered in This Study Table 5. Global Anticoagulants Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Anticoagulants Sales Share by Manufacturers (2015-2020) Table 7. Global Anticoagulants Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Anticoagulants Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Anticoagulants Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Anticoagulants Sales Sites and Area Served Table 11. Manufacturers Anticoagulants Product Types Table 12. Global Anticoagulants Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulants as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Anticoagulants Players Table 16. Global Anticoagulants Sales (K MT) by Region (2015-2020) Table 17. Global Anticoagulants Sales Market Share by Region (2015-2020) Table 18. Global Anticoagulants Revenue (Million US$) by Region (2015-2020) Table 19. Global Anticoagulants Revenue Market Share by Region (2015-2020) Table 20. North America Anticoagulants Sales by Country (2015-2020) (K MT) Table 21. North America Anticoagulants Sales Market Share by Country (2015-2020) Table 22. North America Anticoagulants Revenue by Country (2015-2020) (US$ Million) Table 23. North America Anticoagulants Revenue Market Share by Country (2015-2020) Table 24. Europe Anticoagulants Sales by Country (2015-2020) (K MT) Table 25. Europe Anticoagulants Sales Market Share by Country (2015-2020) Table 26. Europe Anticoagulants Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Anticoagulants Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Anticoagulants Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Anticoagulants Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Anticoagulants Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Anticoagulants Revenue Market Share by Region (2015-2020) Table 32. Latin America Anticoagulants Sales by Country (2015-2020) (K MT) Table 33. Latin America Anticoagulants Sales Market Share by Country (2015-2020) Table 34. Latin America Anticoagulants Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Anticoagulants Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Anticoagulants Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Anticoagulants Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Anticoagulants Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Anticoagulants Revenue Market Share by Country (2015-2020) Table 40. Global Anticoagulants Sales (K MT) by Type (2015-2020) Table 41. Global Anticoagulants Sales Share by Type (2015-2020) Table 42. Global Anticoagulants Revenue (Million US$) by Type (2015-2020) Table 43. Global Anticoagulants Revenue Share by Type (2015-2020) Table 44. Global Anticoagulants Price (USD/MT) by Type (2015-2020) Table 45. Global Anticoagulants Sales (K MT) by Application (2015-2020) Table 46. Global Anticoagulants Sales Market Share by Application (2015-2020) Table 47. Global Anticoagulants Sales Growth Rate by Application (2015-2020) Table 48. Sanofi Anticoagulants Corporation Information Table 49. Sanofi Description and Business Overview Table 50. Sanofi Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Sanofi Main Product Table 52. Sanofi Recent Development Table 53. Bayer Anticoagulants Corporation Information Table 54. Bayer Corporation Information Table 55. Bayer Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Bayer Main Product Table 57. Bayer Recent Development Table 58. Boehringer Ingelheim Anticoagulants Corporation Information Table 59. Boehringer Ingelheim Corporation Information Table 60. Boehringer Ingelheim Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Boehringer Ingelheim Main Product Table 62. Boehringer Ingelheim Recent Development Table 63. Johnson & Johnson Anticoagulants Corporation Information Table 64. Johnson & Johnson Corporation Information Table 65. Johnson & Johnson Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Johnson & Johnson Main Product Table 67. Johnson & Johnson Recent Development Table 68. Genentech (Roche) Anticoagulants Corporation Information Table 69. Genentech (Roche) Corporation Information Table 70. Genentech (Roche) Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Genentech (Roche) Main Product Table 72. Genentech (Roche) Recent Development Table 73. AstraZeneca Anticoagulants Corporation Information Table 74. AstraZeneca Corporation Information Table 75. AstraZeneca Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. AstraZeneca Main Product Table 77. AstraZeneca Recent Development Table 78. Bristol-Myers Squibb Anticoagulants Corporation Information Table 79. Bristol-Myers Squibb Corporation Information Table 80. Bristol-Myers Squibb Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Bristol-Myers Squibb Main Product Table 82. Bristol-Myers Squibb Recent Development Table 83. Aspen Anticoagulants Corporation Information Table 84. Aspen Corporation Information Table 85. Aspen Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Aspen Main Product Table 87. Aspen Recent Development Table 88. Lilly Anticoagulants Corporation Information Table 89. Lilly Corporation Information Table 90. Lilly Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Lilly Main Product Table 92. Lilly Recent Development Table 93. Otsuka Anticoagulants Corporation Information Table 94. Otsuka Corporation Information Table 95. Otsuka Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Otsuka Main Product Table 97. Otsuka Recent Development Table 98. Pfizer Anticoagulants Corporation Information Table 99. Pfizer Corporation Information Table 100. Pfizer Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Pfizer Main Product Table 102. Pfizer Recent Development Table 103. Daiichi Sankyo Anticoagulants Corporation Information Table 104. Daiichi Sankyo Corporation Information Table 105. Daiichi Sankyo Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Daiichi Sankyo Main Product Table 107. Daiichi Sankyo Recent Development Table 108. The Medicines Company Anticoagulants Corporation Information Table 109. The Medicines Company Corporation Information Table 110. The Medicines Company Anticoagulants Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. The Medicines Company Main Product Table 112. The Medicines Company Recent Development Table 113. Sales Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Anticoagulants Distributors List Table 116. Anticoagulants Customers List Table 117. Market Key Trends Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 119. Key Challenges Table 120. Global Anticoagulants Sales (K MT) Forecast by Type (2021-2026) Table 121. Global Anticoagulants Sales Market Share Forecast by Type (2021-2026) Table 122. Global Anticoagulants Revenue (Million US$) Forecast by Type (2021-2026) Table 123. Global Anticoagulants Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 124. Global Anticoagulants Sales (K MT) Forecast by Application (2021-2026) Table 125. Global Anticoagulants Revenue (Million US$) Forecast by Application (2021-2026) Table 126. Global Anticoagulants Sales (K MT) Forecast by Region (2021-2026) Table 127. Global Anticoagulants Sales Market Share Forecast by Region (2021-2026) Table 128. Global Anticoagulants Revenue Forecast by Region (2021-2026) (US$ Million) Table 129. Global Anticoagulants Revenue Market Share Forecast by Region (2021-2026) Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Anticoagulants Figure 2. Global Anticoagulants Sales Market Share by Type: 2020 VS 2026 Figure 3. Platelet aggregation inhibitors (PAI) Product Picture Figure 4. Low-molecular-weight Heparin (LMWH) Product Picture Figure 5. Direct thrombin inhibitor (DTI) Product Picture Figure 6. Direct factor Xa inhibitors (DFXa) Product Picture Figure 7. Vitamin K antagonists (VKA) Product Picture Figure 8. Others Product Picture Figure 9. Global Anticoagulants Consumption Market Share by Application: 2020 VS 2026 Figure 10. VTE Figure 11. ACS/MI Figure 12. AF Figure 13. Other Figure 14. Global Anticoagulants Market Size 2015-2026 (US$ Million) Figure 15. Global Anticoagulants Sales Capacity (K MT) (2015-2026) Figure 16. Global Anticoagulants Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Anticoagulants Sales Share by Manufacturers in 2020 Figure 18. Global Anticoagulants Revenue Share by Manufacturers in 2019 Figure 19. The Global 5 and 10 Largest Players: Market Share by Anticoagulants Revenue in 2019 Figure 20. Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Anticoagulants Sales Market Share by Region (2015-2020) Figure 22. Global Anticoagulants Sales Market Share by Region in 2019 Figure 23. Global Anticoagulants Revenue Market Share by Region (2015-2020) Figure 24. Global Anticoagulants Revenue Market Share by Region in 2019 Figure 25. North America Anticoagulants Sales Market Share by Country in 2019 Figure 26. North America Anticoagulants Revenue Market Share by Country in 2019 Figure 27. U.S. Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 28. U.S. Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Canada Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 30. Canada Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. Europe Anticoagulants Sales Market Share by Country in 2019 Figure 32. Europe Anticoagulants Revenue Market Share by Country in 2019 Figure 33. Germany Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 34. Germany Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. France Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 36. France Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. U.K. Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 38. U.K. Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Italy Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 40. Italy Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Russia Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 42. Russia Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Asia Pacific Anticoagulants Sales Market Share by Region in 2019 Figure 44. Asia Pacific Anticoagulants Revenue Market Share by Region in 2019 Figure 45. China Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 46. China Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Japan Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 48. Japan Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. South Korea Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 50. South Korea Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. India Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 52. India Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Australia Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 54. Australia Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Taiwan Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 56. Taiwan Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Indonesia Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 58. Indonesia Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Thailand Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 60. Thailand Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Malaysia Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 62. Malaysia Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Philippines Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 64. Philippines Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Vietnam Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 66. Vietnam Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Latin America Anticoagulants Sales Market Share by Country in 2019 Figure 68. Latin America Anticoagulants Revenue Market Share by Country in 2019 Figure 69. Mexico Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 70. Mexico Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Brazil Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 72. Brazil Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Argentina Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 74. Argentina Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Middle East and Africa Anticoagulants Sales Market Share by Country in 2019 Figure 76. Middle East and Africa Anticoagulants Revenue Market Share by Country in 2019 Figure 77. Turkey Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 78. Turkey Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Saudi Arabia Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 80. Saudi Arabia Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. U.A.E Anticoagulants Sales Growth Rate (2015-2020) (K MT) Figure 82. U.A.E Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Sales Market Share of Anticoagulants by Type (2015-2020) Figure 84. Sales Market Share of Anticoagulants by Type in 2019 Figure 85. Revenue Share of Anticoagulants by Type (2015-2020) Figure 86. Revenue Market Share of Anticoagulants by Type in 2019 Figure 87. Global Anticoagulants Sales Growth by Type (2015-2020) (K MT) Figure 88. Global Anticoagulants Sales Market Share by Application (2015-2020) Figure 89. Global Anticoagulants Sales Market Share by Application in 2019 Figure 90. Global Revenue Share of Anticoagulants by Application (2015-2020) Figure 91. Global Revenue Share of Anticoagulants by Application in 2020 Figure 92. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Aspen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Price Trend of Key Raw Materials Figure 106. Manufacturing Cost Structure of Anticoagulants Figure 107. Manufacturing Process Analysis of Anticoagulants Figure 108. Anticoagulants Industrial Chain Analysis Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Porter's Five Forces Analysis Figure 112. North America Anticoagulants Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. North America Anticoagulants Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Europe Anticoagulants Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. Europe Anticoagulants Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Latin America Anticoagulants Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Latin America Anticoagulants Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Middle East and Africa Anticoagulants Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 119. Middle East and Africa Anticoagulants Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Asia Pacific Anticoagulants Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 121. Asia Pacific Anticoagulants Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Bottom-up and Top-down Approaches for This Report Figure 123. Data Triangulation Figure 124. Key Executives Interviewed

Sanofi Bayer Boehringer Ingelheim Johnson & Johnson Genentech (Roche) AstraZeneca Bristol-Myers Squibb Aspen Lilly Otsuka Pfizer Daiichi Sankyo The Medicines Company